P23008 (POLG_HRV1A) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 94.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Genome polyprotein Cleaved into the following 5 chains:
|
| Organism | Human rhinovirus 1A (HRV-1A) |
| Taxonomic identifier | 12134 [NCBI] |
| Taxonomic lineage | Viruses › ssRNA positive-strand viruses, no DNA stage › Picornavirales › Picornaviridae › Enterovirus › Rhinovirus A › ![]() |
| Virus host | Homo sapiens (Human) [TaxID: 9606] |
Protein attributes
| Sequence length | 833 AA. |
| Sequence status | Fragments. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Capsid proteins VP1, VP2, VP3 and VP4 form a closed capsid enclosing the viral positive strand RNA genome. VP4 lies on the inner surface of the protein shell formed by VP1, VP2 and VP3. All the three latter proteins contain a beta-sheet structure called beta-barrel jelly roll. Together they form an icosahedral capsid (T=3) composed of 60 copies of each VP1, VP2, and VP3, with a diameter of approximately 300 Angstroms. VP1 is situated at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-sixfold axes. The capsid interacts with human VLDLR to provide virion attachment to target cell. This attachment induces virion internalization predominantly through clathrin-mediated endocytosis By similarity. VP0 precursor is a component of immature procapsids By similarity. |
| Subunit structure | Capsid proteins interact with host VLDLR By similarity. |
| Subcellular location | Protein VP2: Virion. Host cytoplasm Potential. Protein VP3: Virion. Host cytoplasm Potential. Protein VP1: Virion. Host cytoplasm Potential. |
| Post-translational modification | Specific enzymatic cleavages in vivo by the viral proteases yield a variety of precursors and mature proteins. Polyprotein processing intermediates such as VP0 which is a VP4-VP2 precursor are produced. During virion maturation, non-infectious particles are rendered infectious following cleavage of VP0. This maturation cleavage is followed by a conformational change of the particle By similarity. Myristoylation of VP4 is required during RNA encapsidation and formation of the mature virus particle By similarity. |
| Sequence similarities | Belongs to the picornaviruses polyprotein family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Clathrin-mediated endocytosis of virus by host Host-virus interaction Viral attachment to host cell Viral penetration into host cytoplasm Virus endocytosis by host Virus entry into host cell |
| Cellular component | Host cytoplasm Virion |
| Molecular function | Capsid protein |
| PTM | Lipoprotein Myristate |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological_process | viral attachment to host cell Inferred from electronic annotation. Source: UniProtKB-KW viral entry into host cell via clathrin-mediated endocytosisInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | host cell cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell viral capsidInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular_function | structural molecule activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||
Molecule processing | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed; by host | |||||||||||||
| Chain | 2 – 308 | 307 | Protein VP0 Potential | PRO_0000311070 | ||||||||||||
| Chain | 2 – 45 | 44 | Protein VP4 Potential | PRO_0000039995 | ||||||||||||
| Chain | 46 – 308 | 263 | Protein VP2 Potential | PRO_0000039996 | ||||||||||||
| Chain | 309 – 546 | 238 | Protein VP3 Potential | PRO_0000039997 | ||||||||||||
| Chain | 547 – 833 | 287 | Protein VP1 Potential | PRO_0000039998 | ||||||||||||
Sites | ||||||||||||||||
| Site | 45 – 46 | 2 | Cleavage Potential | |||||||||||||
| Site | 308 – 309 | 2 | Cleavage; by picornain 3C Potential | |||||||||||||
Amino acid modifications | ||||||||||||||||
| Lipidation | 2 | 1 | N-myristoyl glycine; by host By similarity | |||||||||||||
Experimental info | ||||||||||||||||
| Non-adjacent residues | 45 – 46 | 2 | ||||||||||||||
| Non-terminal residue | 833 | 1 | ||||||||||||||
Secondary structure | ||||||||||||||||
Helix Strand Turn | ||||||||||||||||
| Beta strand | 3 – 6 | 4 | ||||||||||||||
| Beta strand | 27 – 30 | 4 | ||||||||||||||
| Beta strand | 33 – 35 | 3 | ||||||||||||||
| Helix | 36 – 38 | 3 | ||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Crystal structure of human rhinovirus serotype 1A (HRV1A)." Kim S., Smith T.J., Chapman M.S., Rossmann M.G., Pevear D., Dutko F.J., Felock P.J., Diana G.D., McKinlay M.A. J. Mol. Biol. 210:91-111(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE, X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS). |
| + | Additional computationally mapped references. |
Web resources
| Virus Particle ExploreR db Icosahedral capsid structure in complex with antiviral compound Win56291 |
| Virus Particle ExploreR db Icosahedral capsid structure in complex with antiviral compound Win54954 |
| Virus Particle ExploreR db Icosahedral capsid structure in complex with antiviral compound R61837 |
| Virus Particle ExploreR db Icosahedral capsid structure |
Cross-references
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P23008. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | P23008. Positions 2-45, 56-546, 551-833. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 4.10.80.10. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR003138. Pico_P1A. IPR001676. Picornavirus_capsid. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF02226. Pico_P1A. 1 hit. PF00073. Rhv. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P23008. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | POLG_HRV1A | ||||||||
| Accession | Primary (citable) accession number: P23008 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Viral Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
